We are live on !
Find out more
UBS Portfolio holdings
AUM
$136B
Turnover
18.95%
1-Year Est. Return
16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136B
AUM Growth
+$7.83B
(+6.1%)
Cap. Flow
+$3.56B
Cap. Flow % of AUM
Cap. Flow %
2.62%
Top 10 Holdings %
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,064
Increased
4,754
Reduced
3,910
Closed
1,116
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$387M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$346M |
| 3 |
Crown Castle
CCI
|
+$229M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$218M |
| 5 |
Toronto Dominion Bank
TD
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
APA Corp
APA
|
+$473M |
| 3 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$453M |
| 4 |
Herc Holdings
HRI
|
+$322M |
| 5 |
PETM
PETSMART INC
PETM
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.72% |
| 2 | Energy | 9.22% |
| 3 | Financials | 6.8% |
| 4 | Healthcare | 6.74% |
| 5 | Technology | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
9201
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
| $6K | ﹤0.01% |
1,900
+1,500
| +375% | +$3.92K |
2014 Q1
2 quarters
|
|
9202
CALL
Daktronics
DAKT
$1.01B
| $6K | ﹤0.01% |
500
-700
| -58% | -$8.53K |
2014 Q2
1 quarter
|
|
9203
CALL
DSS Inc
DSS
$5.32M
| $6K | ﹤0.01% |
3
+1
| +50% | +$2.71K |
2014 Q2
1 quarter
|
|
9204
Daxor
DXR
$53.8M
| $6K | ﹤0.01% |
905
+129
| +17% | +$892 |
2013 Q2
5 quarters
|
|
9205
CALL
ProShares Trust UltraShort MSCI Japan
EWV
$4.21M
| $6K | ﹤0.01% |
+25
| New | +$6.1K |
2014 Q3
0 quarters
|
|
9206
PUT
DELISTED
Exact Sciences
EXAS
| $6K | ﹤0.01% |
300
+200
| +200% | +$3.67K |
2014 Q1
2 quarters
|
|
9207
PUT
DELISTED
Foot Locker
FL
| $6K | ﹤0.01% |
+100
| New | +$5.26K |
2014 Q3
0 quarters
|
|
9208
CALL
StealthGas
GASS
$309M
| $6K | ﹤0.01% |
700
| – | – |
2013 Q2
5 quarters
|
|
9209
Harvard Bioscience
HBIO
$37.8M
| $6K | ﹤0.01% |
146
+126
| +630% | +$5.8K |
2013 Q2
5 quarters
|
|
9210
Intellicheck
IDN
$49.7M
| $6K | ﹤0.01% |
1,669
+128
| +8% | +$651 |
2013 Q4
3 quarters
|
|
9211
CALL
IQVIA
IQV
$46.2B
| $6K | ﹤0.01% |
100
-1,200
| -92% | -$67.1K |
2014 Q1
2 quarters
|
|
9212
Jakks Pacific
JAKK
$361M
| $6K | ﹤0.01% |
81
+36
| +80% | +$2.54K |
2014 Q1
2 quarters
|
|
9213
PUT
Jinko Holdings Limited
JKS
$430M
| $6K | ﹤0.01% |
200
-1,000
| -83% | -$28.5K |
2013 Q2
5 quarters
|
|
9214
PUT
Main Street Capital
MAIN
$5.01B
| $6K | ﹤0.01% |
200
-1,500
| -88% | -$47.9K |
2014 Q1
2 quarters
|
|
9215
CALL
Madrigal Pharmaceuticals
MDGL
$10.1B
| $6K | ﹤0.01% |
57
-29
| -34% | -$4.03K |
2013 Q2
5 quarters
|
|
9216
CALL
Mitek Systems
MITK
$860M
| $6K | ﹤0.01% |
2,600
+600
| +30% | +$1.74K |
2013 Q2
5 quarters
|
|
9217
CALL
MillerKnoll
MLKN
$1.46B
| $6K | ﹤0.01% |
+200
| New | +$6.01K |
2014 Q3
0 quarters
|
|
9218
Merit Medical Systems
MMSI
$5.65B
| $6K | ﹤0.01% |
500
-2,242
| -82% | -$29.7K |
2013 Q2
5 quarters
|
|
9219
PUT
MasTec
MTZ
$14.2B
| $6K | ﹤0.01% |
200
+100
| +100% | +$2.97K |
2013 Q2
5 quarters
|
|
9220
Stablecoin Development Corp
SDEV
$48.6M
| – | – |
0
| – | – |
2014 Q1
2 quarters
|
|
9221
PUT
NovaGold Resources
NG
$2.63B
| $6K | ﹤0.01% |
2,000
+500
| +33% | +$1.88K |
2014 Q1
2 quarters
|
|
9222
CALL
Navigator Holdings
NVGS
$1.34B
| $6K | ﹤0.01% |
200
-200
| -50% | -$5.81K |
2014 Q1
2 quarters
|
|
9223
PUT
NatWest
NWG
$67.5B
| $6K | ﹤0.01% |
464
-12,536
| -96% | -$156K |
2013 Q2
5 quarters
|
|
9224
PUT
PACCAR
PCAR
$56.3B
| $6K | ﹤0.01% |
150
-1,350
| -90% | -$56.3K |
2013 Q2
5 quarters
|
|
9225
CALL
Paylocity
PCTY
$9.24B
| $6K | ﹤0.01% |
300
+200
| +200% | +$4.3K |
2014 Q2
1 quarter
|
|
Similar funds
MGC
UBS's Q3 2014 Portfolio in Review
As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS's Q3 2014 filing shows 1,064 new, 4,754 increased, 3,910 reduced and 1,116 closed positions. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Energy and Financials.
- UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
- UBS added most to Amgen in Q3 2014, an estimated $387M increase.
- UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
- UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
- UBS opened 1,064 new positions and closed 1,116 in Q3 2014.
- UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.